Thoughts on Dalvance

Quote



Great drug
Fits a medical need especially with ACO formation and ACA
Biggest challenge is two things
1. Once ASP hits on 4/1 things will change on reimbursement
2. Mentality on skin is narrow among ED ID, need Csuite buiness folks to see the benefit and then manage down.
Pluses
Future indications if kept busy Actavis will make this truly fit an unmet need in Osteo and Pneumonia
For what's it worth
 
















The ASP will go down to reflect the discounts that were given and that will hurt reimbursement unless we lower price on 4/1 to maintain the "spread". It's a great drug that will definitely have a place. There is only room in the market for one of the long acting glycopeptides and between dalbavancin and oritavancin the winner will be dalbavancin. No one is buying oritavancin.
 


You're going to see just how dedicated we are to this drug next week. The IC on the launch will stun you. Best advice is to cast aside the usual BS mentality often displayed on this site and seriously learn the drug and reimbursement structure. You'll want to kick your own ass if you get left behind with this one because there is serious cash to be made on a pretty cool drug.
 


Lots of koolaid drinking on this post. Ask any ID, we have the loser out of these 2 drugs and I agree there is only room for one. Better brush up on my COPD so I can make some $$$.
 


I would love for this drug to be successful, but I have to play devil's advocate for a minute here. If this drug is so great, why have the Durata reps done nothing with it? No vials sold in my territory. What did they do wrong that we will do right?
 


Anonymous said:
Lots of koolaid drinking on this post. Ask any ID, we have the loser out of these 2 drugs and I agree there is only room for one. Better brush up on my COPD so I can make some $$$.
Click to expand...

You're showing you aren't actually a part of this sales force by saying, "brush up on my COPD." You go ahead and sell that COPD hard and make that $$$. Anyone who's actually in the Anti-Infective sales force at Actavis now knows that we have dropped the COPD line from our bag moving forward. And isn't that great?!
 















Write your reply...
Top Bottom
Back
Quote